Change of Immune Cell of ARDS Patients：an Observational Study

• Conditions: Intensive Care Medicine; ARDS
• Interventions: Other: taking blood sample

• Registration Number: NCT02958748
• Lead Sponsor: Southeast University, China

Brief Summary

To evaluate change of different immune cellsduring ARDS and its impact on prognosis.

Detailed Description

Not available

Study Timeline

• Status Verified: 2016-11
• Study Start: 2016-11
• Study First Submitted: 2016-11-06
• Study First Submitted QC: 2016-11-06
• Last Update Submitted: 2016-11-06
• Study First Posted: 2016-11-08
• Last Update Posted: 2016-11-08
• Primary Completion: 2018-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

①sign on the acknowledged

②Diagnosis with ARDS(The Berlin definition），onset within 48hours

Exclusion Criteria

①diagnosis of hematological or immunological disease

②treatment with chemotherapy agents or corticosteroids within 6 months prior to or during the hospitalization.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
ARDS	taking blood sample	Patients admitted to ICU with diagnosis of ARDS,which happened in 48hours.
Control	taking blood sample	Heathy vonlunteers

Primary Outcome Measures

Name	Time	Method
mortality	28-day